We bring you the latest news from the healthcare about the health care in the United Kingdom.

woensdag 23 mei 2018

Nature Reviews Rheumatology - Table of Contents alert Volume 14 Issue 6

If you are unable to see the message below, click here to view.
Nature Reviews Rheumatology
TABLE OF CONTENTS

June 2018 Volume 14, Issue 6

Research Highlights
News & Views
Reviews
Perspectives
 
Advertisement
 

Do you have a career question?


The Naturejobs podcast features one-on-one Q&As, panel discussions and other exclusive content to help scientists with their careers. Hosted on the Naturejobs blog, the podcast is also available on iTunes and Soundcloud. 

Listen today!

 

Research Highlights

 

Synergy of environmental and genetic risk in RA    p319
Nicholas J. Bernard
doi:10.1038/s41584-018-0015-7

Denosumab shows promise for GIOP    p320
Sarah Onuora
doi:10.1038/s41584-018-0016-6

Triple therapy boosts survival in catastrophic APS    p320
Sarah Onuora
doi:10.1038/s41584-018-0017-5

Obesity hampers effects of anti-TNF agents    p320
Sarah Onuora
doi:10.1038/s41584-018-0018-4

Flares not linked to ultrasound findings in JIA    p320
Sarah Onuora
doi:10.1038/s41584-018-0019-3

Surprising safety outcomes of urate-lowering therapy    p320
Jessica McHugh
doi:10.1038/s41584-018-0007-7

Selective p38a MAPK inhibitor shows promise    p321
Jessica McHugh
doi:10.1038/s41584-018-0003-y

Drugs deliver themselves during flares    p321
Joanna Collison
doi:10.1038/s41584-018-0014-8

Bacterial orthologues of Ro60 trigger disease    p322
Joanna Collison
doi:10.1038/s41584-018-0008-6

Fyn-ding a target for OA therapy    p322
Nicholas J. Bernard
doi:10.1038/s41584-018-0020-x

Nature Reviews Rheumatology
JOBS of the week
Principal Medical Education Writer
Springer Nature
More Science jobs from
Nature Reviews Rheumatology
EVENT
6th World Congress on Controversies, Debates & Consensus in Bone, Muscle & Joint Diseases (BMJD)
08.11.18
Bangkok, Thailand
More science events from

News & Views

 

Optimization of CVD prevention in psoriatic arthritis    pp323 - 324
Anne Grete Semb & Silvia Rollefstad
doi:10.1038/s41584-018-0002-z

Neurobiological similarities between RA and fibromyalgia    pp324 - 325
Fabiola Atzeni & Piercarlo Sarzi-Puttini
doi:10.1038/s41584-018-0011-y

Reviews

 

Mitochondrial DNA variation and the pathogenesis of osteoarthritis phenotypes    pp327 - 340
Francisco J. Blanco, Ana M. Valdes & Ignacio Rego-PĂ©rez
doi:10.1038/s41584-018-0001-0

Mitochondrial dysfunction and mitochondrial DNA (mtDNA) influence several molecular processes underlying the pathogenesis of osteoarthritis (OA), and mtDNA variants are associated with the development and progression of knee OA, pointing to a role for mtDNA variation in OA pathogenesis and its phenotypic presentation.

 

An update on the genetics of hyperuricaemia and gout    pp341 - 353
Tanya J. Major, Nicola Dalbeth, Eli A. Stahl & Tony R. Merriman
doi:10.1038/s41584-018-0004-x

In this Review, the authors summarize the results of genetics studies that confirm the importance of modulating urate levels in gout pathophysiology, and discuss how these discoveries could be applied to the treatment of hyperuricaemia and gout.

 

Biomarkers as drug development tools: discovery, validation, qualification and use    pp354 - 362
Virginia B. Kraus
doi:10.1038/s41584-018-0005-9

The use of biomarkers for drug development, clinical investigation and management is fundamental to the success of molecular medicine. This Review discusses the framework for the development of biomarkers as drug development tools, including discovery, analytical validation, clinical qualification and utilization.

 

Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison    pp363 - 371

doi:10.1038/s41584-018-0006-8

Axial disease occurs in psoriatic arthritis (PsA) and ankylosing spondylitis, but questions remain over whether axial PsA is a distinct disease. In this Review, the authors address the current state of knowledge concerning axial PsA and propose a research agenda.

 

Perspectives

 

The role of radiography and MRI for eligibility assessment in DMOAD trials of knee OA    pp372 - 380

doi:10.1038/s41584-018-0010-z

In this Perspectives article, Roemer et al. argue that the time has come to use MRI, rather than radiography, as the primary imaging modality for defining eligibility criteria for clinical trials of potential disease-modifying osteoarthritis drugs (DMOADs).

 

Advertisement
Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours.

Click here to sign up.
 
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant)

For further technical assistance, please contact our registration department

For print subscription enquiries, please contact our subscription department

For other enquiries, please contact our customer feedback department

Springer Nature | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature